JP3899116B1 - 肌荒れ改良剤 - Google Patents
肌荒れ改良剤 Download PDFInfo
- Publication number
- JP3899116B1 JP3899116B1 JP2006183235A JP2006183235A JP3899116B1 JP 3899116 B1 JP3899116 B1 JP 3899116B1 JP 2006183235 A JP2006183235 A JP 2006183235A JP 2006183235 A JP2006183235 A JP 2006183235A JP 3899116 B1 JP3899116 B1 JP 3899116B1
- Authority
- JP
- Japan
- Prior art keywords
- intake
- weeks
- improving agent
- skin
- rough skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000007788 roughening Methods 0.000 title abstract 3
- 239000012528 membrane Substances 0.000 claims abstract description 26
- 230000002611 ovarian Effects 0.000 claims abstract description 25
- 102000035195 Peptidases Human genes 0.000 claims abstract description 7
- 108091005804 Peptidases Proteins 0.000 claims abstract description 7
- 241000972773 Aulopiformes Species 0.000 claims abstract description 5
- 235000019515 salmon Nutrition 0.000 claims abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 7
- 241000251468 Actinopterygii Species 0.000 abstract description 6
- 235000019688 fish Nutrition 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 3
- 235000013402 health food Nutrition 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 39
- 239000003795 chemical substances by application Substances 0.000 description 26
- 230000037303 wrinkles Effects 0.000 description 19
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 18
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 18
- 239000000902 placebo Substances 0.000 description 15
- 229940068196 placebo Drugs 0.000 description 15
- 230000037406 food intake Effects 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Images
Abstract
【解決手段】魚類の卵巣膜から抽出された成分を含む肌荒れ改良剤であり、前記卵巣膜は例えば鮭の卵巣膜であり、前記卵巣膜から抽出された成分は、該卵巣膜をタンパク分解酵素で処理することにより抽出された成分であって、肌荒れ改良剤は例えば錠剤等の形に製剤したものであり、例えば健康食品等の食品として摂取することにより肌荒れの諸症状を緩和、改善することができる。
【選択図】 図1
Description
〔比較例〕
本比較例では、まず、前記実施例の肌荒れ改良剤に代えて、コーンスターチ125mg、乳糖125mgからなるプラセボ(偽薬)を、直径8mmの錠剤の形に製剤した。
Claims (1)
- 鮭の卵巣膜をタンパク分解酵素で処理することにより抽出された成分を含むことを特徴とする肌荒れ改良剤。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006183235A JP3899116B1 (ja) | 2006-07-03 | 2006-07-03 | 肌荒れ改良剤 |
KR1020070066257A KR101301037B1 (ko) | 2006-07-03 | 2007-07-02 | 항노화제 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006183235A JP3899116B1 (ja) | 2006-07-03 | 2006-07-03 | 肌荒れ改良剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP3899116B1 true JP3899116B1 (ja) | 2007-03-28 |
JP2008013442A JP2008013442A (ja) | 2008-01-24 |
Family
ID=37942117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006183235A Active JP3899116B1 (ja) | 2006-07-03 | 2006-07-03 | 肌荒れ改良剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3899116B1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1938866A2 (en) * | 2006-12-22 | 2008-07-02 | Nippon Barrier Free Co. Ltd. | Cosmetic product comprising a component extracted from a Salmonidae fish ovarian |
JP2011026223A (ja) * | 2009-07-23 | 2011-02-10 | Noevir Co Ltd | 皮膚外用剤 |
JP2012255036A (ja) * | 2012-10-02 | 2012-12-27 | Nippon Barrier Free:Kk | アンチエイジング剤 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5449730B2 (ja) * | 2008-09-29 | 2014-03-19 | 協和薬品株式会社 | 更年期障害改善剤及び栄養補助食品 |
-
2006
- 2006-07-03 JP JP2006183235A patent/JP3899116B1/ja active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1938866A2 (en) * | 2006-12-22 | 2008-07-02 | Nippon Barrier Free Co. Ltd. | Cosmetic product comprising a component extracted from a Salmonidae fish ovarian |
EP1938866A3 (en) * | 2006-12-22 | 2009-04-08 | Nippon Barrier Free Co. Ltd. | Cosmetic product comprising a component extracted from a Salmonidae fish ovarian |
JP2011026223A (ja) * | 2009-07-23 | 2011-02-10 | Noevir Co Ltd | 皮膚外用剤 |
JP2012255036A (ja) * | 2012-10-02 | 2012-12-27 | Nippon Barrier Free:Kk | アンチエイジング剤 |
Also Published As
Publication number | Publication date |
---|---|
JP2008013442A (ja) | 2008-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5887630B2 (ja) | ジペプチジルペプチダーゼ−iv阻害剤の製造方法 | |
TWI516280B (zh) | 紅藜萃取物用於製備促進膠原蛋白生成及抗皮膚老化之組合物之用途 | |
CN104540960B (zh) | 胶原肽组合物的制造方法、dpp‑4阻碍剂和血糖值升高抑制剂 | |
JP3899116B1 (ja) | 肌荒れ改良剤 | |
JP3946238B1 (ja) | Igf−1値上昇剤 | |
JP5027001B2 (ja) | 酵素処理ローヤルゼリー及びそれを含有する皮膚繊維芽細胞の増殖促進剤 | |
JPWO2011016220A1 (ja) | ジペプチジルペプチダーゼ−4阻害剤 | |
JP4917584B2 (ja) | 可溶化蜂の子処理物、その製造方法、抗酸化剤、ace阻害剤、血圧降下剤、皮膚繊維芽細胞増殖促進剤、疲労回復剤、血流改善剤、並びに可溶化蜂の子処理物を含有する医薬品、化粧品又は飲食品 | |
JP4132635B2 (ja) | 未失活酵素強化組成物 | |
KR20100028258A (ko) | 다시마의 발효에 의한 다량의 gaba를 함유한 발효산물 및 이를 이용한 기능성 천연 발효조미료와 다시마 발효분말의 제조 방법 | |
JP2012255036A (ja) | アンチエイジング剤 | |
JP3946239B1 (ja) | 加速度脈波加齢指数上昇剤 | |
JP2008037770A (ja) | 抗加齢剤 | |
JP5449730B2 (ja) | 更年期障害改善剤及び栄養補助食品 | |
JP2008074734A (ja) | インスリン抵抗性改善剤 | |
JP2008019181A (ja) | 月経痛及び/又は月経前症候群の症状の予防及び/又は治療用組成物 | |
JP6544503B2 (ja) | コラゲナーゼ阻害剤、並びにコラゲナーゼ阻害剤を配合した化粧料組成物及び機能性食品 | |
KR100844386B1 (ko) | 오징어 콜라겐으로부터 피부주름 억제활성을 갖는펩타이드를 제조하는 방법 및 그 제조물 | |
JP6154029B2 (ja) | 睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤 | |
CN111165829A (zh) | 一种用于刺激胰岛素分泌的食品或保健品 | |
KR102306903B1 (ko) | 미생물 대사산물을 포함하는 조성물 및 그 제조방법 | |
JP5668018B2 (ja) | アルコール摂取障害予防剤 | |
JP2017195830A (ja) | 脂肪蓄積予防用の食品組成物 | |
CN117482214A (zh) | 一种改善中老年失眠的水解酪蛋白肽及其制备方法和应用 | |
US20220387545A1 (en) | Collagen hydrolysate as active substance against periodontitis or gingivitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20061205 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20061222 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 3899116 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110105 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110105 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120105 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120105 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130105 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130105 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140105 Year of fee payment: 7 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |